News & Analysis as of

Bayh-Dole Act Stem cells

Fenwick & West LLP

IP Provisions and ROI for State-Funded Stem Cell-Based Products and Technologies in California

Fenwick & West LLP on

The California Institute of Regenerative Medicine (CIRM) reaches the end of its initial charter in 2017 and recently published its Transition Plan. The plan is a roadmap to sustained development of stem cell-based...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide